Report copyright - PRACTICE CHANGING STUDIES IN GASTROINTESTINAL … · safety, PK, QoL Treatment arm A Treatment arm B Trastuzumab + pertuzumab 840 mg IV q3w Trastuzumab + placebo IV q3w • Geographical
Please pass captcha verification before submit form